International journal of biological macromoleculesAnimalsChitosanDendritic CellsCancer VaccinesMice
DCs-targeted full-cell nanovaccine based on chitosan oligosaccharide self-assembled with ganoderma lucidum polysaccharide for enhancing tumor immunotherapy.
Wenjun Hu, Yun Ma, Qing Zhang, Qin Zhang, Xingtai Yu, Haojie Wang, Tianxin Wu, Zhijun Chen, Jakkree Tangthianchaichana, Shouying Du, Yang Lu
Published: 202510.1016/j.ijbiomac.2025.148934
Abstract
Tumor vaccines, designed to deliver immunogenic antigens and initiate tumor-specific immune responses, hold significant promise for cancer prevention and therapy. However, their efficacy remains limited by the inherently low immunogenicity of tumor a…
Preview only. Read the full abstract at the source